GlassScriptPhysician profile
Roy M Greenway
NPI 1639219108
$3,892.10
in general payments reported to CMS, 2019-2025
9 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $603 · 2021: $28.21 · 2022: $1,323 · 2023: $27.57 · 2024: $1,551 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $908 · Food and Beverage: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $908.18 |
| Food and Beverage | $842.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,699.43 | 2024-2025 | Apollo Esg Nxt System, Overstitch Nxt Endoscopic Suturing System, Apollo Esg System |
| Medtronic, INC. | $1,103.95 | 2021-2022 | |
| Covidien LP | $656.47 | 2019-2020 | |
| Stryker Corporation | $133.97 | 2019 | |
| Ethicon US, LLC | $124.99 | 2022 | |
| Lexington Medical, INC. | $108.50 | 2022 | |
| Heron Therapeutics, INC. | $27.57 | 2023 | Zynrelef |
| Teleflex LLC | $23.55 | 2024 | Titan Sgs |
| Braintree Laboratories, INC. | $13.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Greenway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.